HOME - News - Market
 
 
07 December 2023

Mojdeh Poul and Kevin Conroy Join Align Technology Board of Directors


Align Technology announced that its board of directors has appointed Mojdeh Poul, former EVP and group president of 3M Health Care, and Kevin Conroy, president, chief executive officer, and chairman of the board of exact sciences.

“I am pleased to welcome Mojdeh and Kevin to Align’s board of directors,” said Joe Hogan, president and CEO of Align Technology. “Each brings extensive experience across the healthcare industry that complements the depth and breadth of Align’s board. Mojdeh has led global businesses and operations in large multinational organizations and has deep expertise in business strategy and transformation, as well as commercial excellence. Kevin has an exceptional track-record for growth and his technical and clinical expertise, combined with a focus on digitally innovative solutions, have delivered amazing customer experiences. Mojdeh and Kevin are both outstanding additions to our board and I am confident that their knowledge and insights will benefit Align as we continue to drive the evolution of digital orthodontics and restorative dentistry globally.”

Mojdeh Poul most recently served as the executive vice president and group president of 3M Health Care, overseeing its global profit and loss (P&L), strategy, research & development, manufacturing, and commercial operations. During her tenure at 3M, Ms. Poul held various leadership roles, including executive vice president of the Safety & Graphics Business Group, president of 3M Canada, and president of two divisions within the 3M Health Care Business Group. Before joining 3M, Ms. Poul held progressive leadership positions at leading global medical technology companies, Medtronic and Boston Scientific. Additionally, she had engineering roles at General Electric Plastics.

Currently, Ms. Poul serves as a director of iRhythm Technologies and Stanley Black and Decker. She holds an M.B.A. from the University of North Carolina, Chapel Hill, and M.Eng. and B.S. degrees in Mechanical Engineering from the University of Louisville.

Kevin Conroy is the president, chief executive officer, and chairman of the board of Exact Sciences Corporation. Appointed as CEO in 2009 and Chairman in 2014, Mr. Conroy transformed the organization into a premier cancer diagnostics company. Under his leadership, Exact Sciences developed and commercialized Cologuard, a noninvasive colorectal cancer screening test, which received simultaneous FDA approval and national Medicare coverage. Before Exact Sciences, Mr. Conroy served as CEO and president of Third Wave Technologies, held leadership positions at GE Healthcare, and practiced intellectual property law. He previously served as a director of Adaptive Biotechnologies Corporation, Epizyme, Inc., and SomaLogic, Inc. Mr. Conroy holds a J.D. from the University of Michigan Law School and a B.S.E. in electrical engineering from Michigan State University.

About Align Technology, Inc.

Align Technology designs and manufactures the Invisalign System, the world’s most advanced clear aligner system, iTero intraoral scanners and services, and exocad CAD/CAM software. These technology components enhance digital orthodontic and restorative workflows, benefiting over 252 thousand doctor customers and playing a key role in accessing Align’s 600 million consumer market opportunity worldwide.


Source: www.aligntech.com

Related articles

Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear aligners, iTero intraoral scanners,...


Series of new features enable patients to see their comprehensive oral health condition and potential future Invisalign® smile through dynamic visuals at chairside on an iTero scanner.


Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear aligners, iTero intraoral scanners,...


Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear aligners, iTero intraoral scanners,...


The Invisalign Palatal Expander is applicable to skeletal and dental malocclusion in primary, mixed, and permanent dentition and will be commercially available during the second half of 2025.


Read more

Dentistry Today recently attended a robotic-assisted dental implant procedure performed by Jay Neugarten, DDS, MD, FACS, utilizing the Yomi S robotic guidance s


State funding will create dedicated space for pediatric and adolescent care and improve access for people with disabilities across the lifespan


 
 
 
 

 
 
 
 

Most popular

 
 

Events